Type 2 diabetes management has evolved rapidly over the past decade. As new therapies improve glucose control and cardiometabolic outcomes, many patients achieve better metabolic stability than before. However, this progress often comes with a challenge: medication overload. Deprescribing in diabetes care has emerged as a thoughtful clinical approach that …
Read More »Implementing CKM Staging in Primary Care: From Concept to Workflow
The concept of CKM staging in primary care has gained attention as clinicians look for better ways to manage the growing overlap between cardiovascular disease, kidney disease, diabetes, and metabolic disorders. However, many providers still wonder how to translate the CKM framework into daily clinical practice. Think of CKM staging …
Read More »GLP-1s and Gastrointestinal Safety in Long-Term Use: What Happens After Year Three?
GLP-1 receptor agonists have transformed diabetes care, but the long-term safety of GLP-1 therapies has become an important topic as treatment continues for many years. Initially, clinicians prescribed these medications primarily for glycemic control in patients with type 2 diabetes. However, their role has expanded due to additional benefits in …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.